Aura Biosciences, Inc. - AURA

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$358.6M

QoQ value delta ($000)

+$84.83M (+30.99%)

Implied price effect (QoQ)

+21.5%

Total shares

54,157,125

QoQ shares delta

+3,922,171 (+7.81%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 127 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
Matrix Capital Management Company, LP	46,314	6,922,870	100.0%
Frazier Life Sciences Management, L.P.	34,119	5,100,000	0.88%
ADAGE CAPITAL PARTNERS GP, L.L.C.	32,654	4,881,125	0.05%
Long Focus Capital Management, LLC	30,905	4,619,582	0.81%
SUVRETTA CAPITAL MANAGEMENT, LLC	29,254	4,372,884	0.75%
BlackRock, Inc.	23,994	3,586,640	0.0%
Medicxi Ventures Management (Jersey) Ltd	20,336	3,039,892	2.07%
VANGUARD GROUP INC	16,004	2,936,538	0.0%
VANGUARD CAPITAL MANAGEMENT LLC	15,011	2,243,828	0.0%
Nantahala Capital Management, LLC	14,167	2,117,697	0.52%
FRANKLIN RESOURCES INC	13,866	2,072,726	0.0%
GEODE CAPITAL MANAGEMENT, LLC	8,770	1,310,862	0.0%
MILLENNIUM MANAGEMENT LLC	7,343	1,097,627	0.0%
STATE STREET CORP	6,453	964,670	0.0%
LEVIN CAPITAL STRATEGIES, L.P.	6,297	941,400	0.48%
B Group, Inc.	3,997	597,576	2.96%
ACORN CAPITAL ADVISORS, LLC	3,985	595,744	1.13%
DIMENSIONAL FUND ADVISORS LP	3,731	558,158	0.0%
BALYASNY ASSET MANAGEMENT L.P.	3,730	557,654	0.0%
Regency Capital Management Inc.\DE	3,562	532,495	1.59%
NORTHERN TRUST CORP	2,880	430,522	0.0%
PRICE T ROWE ASSOCIATES INC /MD/	2,779	415,191	0.0%
VANGUARD FIDUCIARY TRUST CO	2,657	397,160	0.0%
VANGUARD PORTFOLIO MANAGEMENT LLC	2,618	391,334	0.0%
JANE STREET GROUP, LLC	1,617	241,800	0.0%